Harbor Light Capital Partners

Harbor Light Capital Partners, established in 2008 and based in Keene, New Hampshire, is a private equity firm that specializes in making investments in the range of $1 million to $5 million. The firm primarily targets early-stage companies in the healthcare, biotechnology, and technology sectors, particularly those based in New England and the Intermountain West. Harbor Light Capital Partners distinguishes itself by prioritizing long-term growth over traditional investment timelines, allowing for a flexible approach tailored to the specific needs of family-owned and emerging growth businesses. The firm seeks to partner with companies that demonstrate innovative or disruptive technologies, strong intellectual property, and significant market opportunities. Additionally, it emphasizes the importance of exceptional management teams and aims to actively engage at the board and operational levels to drive growth, leveraging its expertise and networks to enhance value and facilitate expansion.

Gordon Finnegan

Principal

Richard Upton

General Partner

Todd Warden

Managing Partner

16 past transactions

Carmell Therapeutics

Series B in 2017
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Courtagen Life Sciences

Private Equity Round in 2015
Courtagen Life Sciences is a privately held life science company that provides innovative proteomic and genomic products and services to the Life Sciences industry. Founded by innovators in next-generation sequencing (NGS), genetics, molecular biology, and information science, our company deliver tools that enable researchers and clinicians to make better decisions regarding drug development and patient care.

Senet

Series A in 2015
Senet offers a low cost, long distance sensor network, and high-value SaaS applications on a subscription fee basis to help businesses make fact-based decisions. Senet's cost-effective, highly-scalable network enables companies to capitalize on opportunities in the rapidly growing Machine-to-Machine (M2M) Internet of Things (IoT) landscape.

Carmell Therapeutics

Series A in 2014
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Alcyone Lifesciences

Series B in 2014
Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain. It addresses the unmet needs in the treatment of chronic neuropathological conditions. For many neurologic conditions, there are identified molecular targets, but the blood-brain barrier prevents drugs from addressing those targets from reaching diseased brain regions in a controlled and targeted manner. In addition, there is a fundamental need for control and precision in molecular therapy to the CNS. The company is transforming disease-modifying therapies for rare and orphan disorders through Advanced Precision Delivery Platforms.

Terascala

Venture Round in 2013
Headquartered in Boston, Terascala is the fast data company. Terascala storage appliances dramatically accelerate the time to insight for organizations that rely on simulation, analysis, and modeling tools to bring new products and innovation to market. Exclusively available through strategic partners Dell, EMC, and NetApp, Terascala storage appliances provide on-demand throughput at multiple gigabytes per second while leveraging industry-leading storage platforms for long-term data protection.

EnerTrac

Series A in 2013
EnerTrac saves fuel and reduces emissions by automating the measuring and monitoring processes of devices that have historically required manual reading and recording. EnerTrac innovative low frequency and low cost monitoring and communications network provides delivery companies with actionable data that makes their delivery schedules more targeted and more efficient. EnerTrac technology facilitates machine to machine (M-2-M) communication and is currently being used to automate the monitoring of fuel oil and propane fuel tanks. The network that EnerTrac is establishing could ultimately be extended to monitor thermostats, flow meters, heating, ventilation and air conditioning systems.

Draker

Venture Round in 2012
For over a decade, Draker has been providing monitoring, management and control solutions for commercial and utility solar energy systems. Draker’s range of products and services allows PV developers, owners and operators to increase efficiency and optimize profitability of their solar assets. Draker’s turnkey commercial and end-to-end utility solutions include project-based services, field instrumentation, data collection and management, robust web applications with advanced analytical tools, and public information displays.

Vets First Choice

Venture Round in 2012
Vets First Choice provides veterinary practices with an online pharmacy and home delivery services. It partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. The company was founded by Ben Shaw in 2010 and is based in Portland, Maine.

Courtagen Life Sciences

Series B in 2011
Courtagen Life Sciences is a privately held life science company that provides innovative proteomic and genomic products and services to the Life Sciences industry. Founded by innovators in next-generation sequencing (NGS), genetics, molecular biology, and information science, our company deliver tools that enable researchers and clinicians to make better decisions regarding drug development and patient care.

Draker

Venture Round in 2011
For over a decade, Draker has been providing monitoring, management and control solutions for commercial and utility solar energy systems. Draker’s range of products and services allows PV developers, owners and operators to increase efficiency and optimize profitability of their solar assets. Draker’s turnkey commercial and end-to-end utility solutions include project-based services, field instrumentation, data collection and management, robust web applications with advanced analytical tools, and public information displays.

Carmell Therapeutics

Series A in 2011
Carmell Therapeutics Corporation manufactures plasma-based biologically-active plastic medical devices from blood plasma for treating injuries to bone and connective tissue. The company’s products include REPAIR bone putty, a putty form of the plasma-based plastics to fill bone defects; and a surgical scaffold that accelerates the healing of injured tendons and ligaments for soft tissue repair. It focuses on the sports medicine market. The company was founded in 2007 and is based in Pittsburgh, Pennsylvania.

Micronotes

Venture Round in 2010
Micronotes is an AI-enabled cloud-based marketing automation company serving financial service providers. The company’s fast, automated and cloud-based digital interview platform applies machine learning to customer data to improve customer engagement and effectively cross-sell financial services through the digital service channels. We are headquartered in Boston, MA at the Cambridge Innovative Center (CIC).

Eggrock Partners

Venture Round in 2009
Eggrock Partners, Inc. operates as a consulting and systems integration company that focuses on delivering e-business solutions to emerging enterprises. The company is based in Concord, Massachusetts. As of March 31, 2000, Eggrock Partners, L.L.C. is a subsidiary of Breakaway Solutions, Inc.

FetchDog

Series A in 2009
[FetchDog](http://www.fetchdog.com) is a website for dog owners.

Draker

Series A in 2008
For over a decade, Draker has been providing monitoring, management and control solutions for commercial and utility solar energy systems. Draker’s range of products and services allows PV developers, owners and operators to increase efficiency and optimize profitability of their solar assets. Draker’s turnkey commercial and end-to-end utility solutions include project-based services, field instrumentation, data collection and management, robust web applications with advanced analytical tools, and public information displays.